About BioSerenity

About BIOSerenity

BIOSerenity is an integrated neuroscience platform. From the production of connected medical devices to collaborative telemedicine, it completes the range of care offered in the diagnosis of brain pathologies and adjacent fields such as sleep disorders and cardiology. It enhances current protocols through the appropriate use of artificial intelligence. 

Key Figures

9,000

referring physicians

300+

partner hospitals and clinics

49,000

EEGs performed in 2025 – equal to top 15 university hospitals combined

7

Sleep diagnostic centers performing Polysomnographies and respiratory polygraphy.

Management

Emmanuel Mougeotte CEO

Board Members

Jean Schmitt
Board member
Jolt Capital

Marie-Nicod-Jolt-Capital-300

Marie Nicod
Board member
Jolt Capital

Valéry Huot
Board member
LBO France

Frederic-KOEHN-300

Frédéric Koehn
Board member
Independant

Dan Newman
Observer
Jolt Capital

Sébastien Woynar
Observer
LBO France

Medical and Scientific Board

Pr Sylvie N'Guyen The Tich

Neuropediatrician, Head of Pediatric Neurology Department, Lille University Hospital, France
General Secretary of the French Society of Neuropediatrics

Pr Iona Mindruta

Neurologist, Head of the Epilepsy Monitoring Unit at Bucharest University Hospital, Romania.

Dr Laurent Koessler

Biomedical Engineer, Phd in Neurosciences
Research Director in Bioemedical engineering and neuroimaging at CNRS.

Pr Philippe Derambure

Neurologist, Deputy Head of Division and Head of Department, Clinical Neurophysiology – Epilepsy – EEG at Lille Hospital, France.

Pr Louis Maillard

Neurologist, Head of the Epileptology Unit at Nancy University Hospital, France

Pr Nicolas Gaspard

Professor and Head of Neurology Department, Erasmus Hospital, Brussels, Belgium